Activity of cefepime/zidebactam (WCK 5222) against Enterobacteriaceae, Pseudomonas aeruginosa and Acinetobacter baumannii endemic to New York City medical centres

Strategic Approaches to Overcome Resistance against Gram-Negative Pathogens Using β-Lactamase Inhibitors and β-Lactam Enhancers: Activity of Three Novel Diazabicyclooctanes WCK 5153, Zidebactam (WCK 5107), and WCK 4234

(2018) Krisztina M. Papp-Wallace et al.   JOURNAL OF MEDICINAL CHEMISTRY

Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis

(2018) Evelina Tacconelli et al.   LANCET INFECTIOUS DISEASES

Vital Signs: Containment of Novel Multidrug-Resistant Organisms and Resistance Mechanisms — United States, 2006–2017

(2018) Kate Russell Woodworth et al.   MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT

Assessment of the In Vivo Efficacy of WCK 5222 (Cefepime-Zidebactam) Against Carbapenem-Resistant Acinetobacter baumannii in the Neutropenic Murine Lung Infection Model

(2018) Lindsay M. Avery et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Carbapenemases in New York City: the continued decline of KPC-producing Klebsiella pneumoniae, but a new threat emerges

(2018) Alejandro Iregui et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

In Vivo Efficacy of Humanized WCK 5222 (Cefepime-Zidebactam) Exposures against Carbapenem-Resistant Acinetobacter baumannii in the Neutropenic Thigh Model

(2018) Safa S. Almarzoky Abuhussain et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

WCK 5222 (cefepime/zidebactam) antimicrobial activity tested against Gram-negative organisms producing clinically relevant β-lactamases

(2017) Helio S. Sader et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

In vitro activity of cefepime/zidebactam (WCK 5222) against Gram-negative bacteria

(2017) David M. Livermore et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Rise and fall of KPC-producingKlebsiella pneumoniaein New York City

(2016) Marie Abdallah et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Reduction in the prevalence of carbapenem-resistant Acinetobacter baumannii and Pseudomonas aeruginosa in New York City

(2015) Marie Abdallah et al.   AMERICAN JOURNAL OF INFECTION CONTROL

Clinical epidemiology of the global expansion of Klebsiella pneumoniae carbapenemases

(2013) L Silvia Munoz-Price et al.   LANCET INFECTIOUS DISEASES

Contribution of OmpK36 to carbapenem susceptibility in KPC-producing Klebsiella pneumoniae

(2009) D. Landman et al.   JOURNAL OF MEDICAL MICROBIOLOGY

Correlation of Antimicrobial Resistance with  -Lactamases, the OmpA-Like Porin, and Efflux Pumps in Clinical Isolates of Acinetobacter baumannii Endemic to New York City

(2008) S. Bratu et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY